Financials

  • Market Capitalization 11.73 M
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.75
Price to sales ratio
4 724.35

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4783
CMMB
Chemomab Therapeutics Ltd - American Depositary Shares
1.63 USD-1.21%-29.44%-6.32%+10.51%11.72 M USD
4785
MBRX
Moleculin Biotech, Inc. - Common Stock
2.21 USD0.00%-5.15%-18.15%-29.84%11.79 M USD
4791
GDTC
CytoMed Therapeutics Limited - Ordinary Shares
0.96 USD0.00%0.00%-12.73%-55.35%11.36 M USD
4796
KPRX
Kiora Pharmaceuticals, Inc. - Common Stock
2.48 USD+0.81%-3.13%-2.75%+18.10%10.99 M USD

Frequently asked questions about Phio Pharmaceuticals Corp. - Common Stock

What is the Phio Pharmaceuticals Corp. - Common Stock stock price today?

The current price of Phio Pharmaceuticals Corp. - Common Stock (PHIO) is 1.01. Over the past 24 hours, the stock has changed by +1.00%. Follow the PHIO chart for real-time price dynamics.

What is the stock ticker of Phio Pharmaceuticals Corp. - Common Stock?

Phio Pharmaceuticals Corp. - Common Stock trades under the ticker PHIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Phio Pharmaceuticals Corp. - Common Stock stock going up?

PHIO has changed by 0.00% over the last week, -7.34% over the last month, and -15.13% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Phio Pharmaceuticals Corp. - Common Stock net income for the last quarter?

Phio Pharmaceuticals Corp. - Common Stock reported net income of -4 M for the last quarter. The previous quarter showed -2.37 M, which means net income changed by -68.83%.

How many employees does Phio Pharmaceuticals Corp. - Common Stock have?

As of the latest available data, Phio Pharmaceuticals Corp. - Common Stock has 6 employees. Workforce size can provide additional context about the company's scale and operations.

What is Phio Pharmaceuticals Corp. - Common Stock EBITDA?

Phio Pharmaceuticals Corp. - Common Stock EBITDA is -4.16 M, and its EBITDA margin is -138.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Phio Pharmaceuticals Corp. - Common Stock stock?

You can buy Phio Pharmaceuticals Corp. - Common Stock (PHIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Phio Pharmaceuticals Corp. - Common Stock stock?

Investing in Phio Pharmaceuticals Corp. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHIO chart and related analysis on metatrader.com as part of your research.

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

News